Your browser doesn't support javascript.
loading
Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
Wan, Hongquan; Qi, Li; Gao, Jin; Couzens, Laura K; Jiang, Lianlian; Gao, Yamei; Sheng, Zong-Mei; Fong, Sharon; Hahn, Megan; Khurana, Surender; Taubenberger, Jeffery K; Eichelberger, Maryna C.
Affiliation
  • Wan H; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Qi L; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Gao J; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Couzens LK; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Jiang L; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Gao Y; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Sheng ZM; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Fong S; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Hahn M; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Taubenberger JK; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Eichelberger MC; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA maryna.eichelberger@fda.hhs.gov.
J Virol ; 92(4)2018 02 15.
Article in En | MEDLINE | ID: mdl-29167344
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Proteins / Orthomyxoviridae Infections / Antibodies, Monoclonal / Antibodies, Viral / Neuraminidase Type of study: Prognostic_studies Limits: Animals / Female / Humans Country/Region as subject: Asia Language: En Journal: J Virol Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Proteins / Orthomyxoviridae Infections / Antibodies, Monoclonal / Antibodies, Viral / Neuraminidase Type of study: Prognostic_studies Limits: Animals / Female / Humans Country/Region as subject: Asia Language: En Journal: J Virol Year: 2018 Document type: Article